Risk of invasive breast cancer in Mexican population and patterns of screening and prophylaxis;Riesgo de cáncer de mama invasor en población mexicana y patrones de escrutinio y profilaxis

Revista de Investigacion Clinica

Volumn 56, Issue 4, 2004, Pages 422-426

  Medina Franco, Heriberto ^a   Garza, Esther ^a   Gabilondo, Bernardo ^a   Gaona Luviano, Patricia ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Breast cancer; Prophylaxis; Risk; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEXICO; POPULATION RESEARCH; POSTMENOPAUSE; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE DIFFERENCE; RISK ASSESSMENT; STATISTICAL MODEL; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MASS SCREENING; MEXICO; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK FACTORS;

EID: 7444260892     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Macias-Martinez G, Kuri-Morales P. Resultado del registro histopatológico de neoplasias en México 1995. Gac Med Mex 1998; 134: 337-42.
2. Gail MH, Brinton LA, Byar DP y cols. Projecting individualizad probabilities of developing breast cancer for white females who are being examined annualy. J Natl Cancer Inst 1989; 81: 1879-83.
3. Benichou J, Gail MH, Mulvihil JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103-10.
4. Claus EG, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994; 73: 643-9.
5. Fisher B, Constantino JP, Wickerham DL y cols. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-8.
6. Gail MH, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 1998; 19: 1315-20.
7. Madigan M, Ziegler R, Benichon C y cols. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87: 1681-9.
8. Claus EB, Schilkraut JM, Thompson WE, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318-21.
9. Struewing JP, Hartge P, Wacholder S y cols. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-7.
10. Spiegelman D, Colditz GA, Huner D, Hertzmark E. Validation of the Gail et al model for predicting individual breast cancer risk. J Natl Cancer Inst 1994; 86: 600-5.
11. Bondy M, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994; 86: 620-6.
12. Constantino JP, Gail MH, Pee D y cols. Validation studies for models projecting the risk of invasive breast cancer incidence. J Natl Cancer Inst 1999; 91: 1541-7.
13. Tabar L, Fageberg CJG, Gad A, y cols. Reduction in mortality for breast cancer alter mass screening with mammography. Randomized trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-32.
14. Gastrin G, Miller AB, To T y cols. Incidence and mortality from breast cancer in the mama program for breast cancer screening in Finland, 1973-1986. Cancer 1994; 73: 2168-74.
15. Nystrom L, Rutqvist LE, Wall S y cols. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993; 341: 973-8.
16. Rodríguez-Cuevas S, Macias CG, Francesschi D, Labastida S. Breast carcinoma presents a decade earlier in mexican women than in women in the United Status or European Countries. Cancer 2001; 91: 863-8.
17. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of randomized trials. Lancet 1998; 352: 930-6.
18. Powles T, Eeles B, Ashley S y cols. Interin analysis of the incidence of breast cancer in the Royal Mrsden Hospital tamoxifen randomized chemoprevention trial. Lancet 1998; 352: 98-103.
19. Veronesi U, Maisonneuve P, Cota A, y cols. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 1998; 352: 93-8.